Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.
Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P.
Brain Res. 2012 Jan 13;1432:95-113. Epub 2011 Nov 19.
Related citations
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa MM, Manivasagam T.
Brain Res. 2012 Jan 18;1433:104-13. Epub 2011 Nov 13.
Retraction notice to “Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease” [Brain Res. Rev. 65 (2010) 1-13].
[No authors listed]
Brain Res. 2011 Oct 24;1419:117. No abstract available.
Preservation of function in Parkinson's disease: what's learning got to do with it?
Beeler JA.
Brain Res. 2011 Nov 14;1423:96-113. Epub 2011 Sep 29. Review.
Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease.
Zheng LF, Wang ZY, Li XF, Song J, Hong F, Lian H, Wang Q, Feng XY, Tang YY, Zhang Y, Zhu JX.
Brain Res. 2011 Oct 28;1420:59-67. Epub 2011 Sep 9.
Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease.
Yue X, Falk T, Zuniga LA, Szabò L, Porreca F, Polt R, Sherman SJ.
Brain Res. 2011 Sep 21;1413:72-83. Epub 2011 Jul 23.
CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.
LeWitt P, Schultz L, Auinger P, Lu M; Parkinson Study Group DATATOP Investigators.
Brain Res. 2011 Aug 23;1408:88-97. Epub 2011 Jul 1.
An α-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons.
Khodr CE, Sapru MK, Pedapati J, Han Y, West NC, Kells AP, Bankiewicz KS, Bohn MC.
Brain Res. 2011 Jun 13;1395:94-107. Epub 2011 Apr 22.
Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease.
Wu G, Wang X, Feng X, Zhang A, Li J, Gu K, Huang J, Pang S, Dong H, Gao H, Yan B.
Brain Res. 2011 Jun 7;1394:105-11. Epub 2011 Apr 13.
PITX3 gene polymorphism is associated with Parkinson's disease in Chinese population.
Liu J, Sun QY, Tang BS, Hu L, Yu RH, Wang L, Shi CH, Yan XX, Pan Q, Xia K, Guo JF.
Brain Res. 2011 May 25;1392:116-20. Epub 2011 Apr 6.
Degeneration of mesencephalic dopaminergic neurons in klotho mouse related to vitamin D exposure.
Kosakai A, Ito D, Nihei Y, Yamashita S, Okada Y, Takahashi K, Suzuki N.
Brain Res. 2011 Mar 25;1382:109-17. Epub 2011 Jan 27.
Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein.
Chadchankar H, Ihalainen J, Tanila H, Yavich L.
Brain Res. 2011 Mar 25;1382:37-44. Epub 2011 Jan 26.
Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K, Inada T, Shingu K.
Brain Res. 2011 Apr 28;1387:125-33. Epub 2011 Mar 2.
Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
Wang CY, Xu Q, Weng L, Zhang Q, Zhang HN, Guo JF, Tan LM, Tang JG, Yan XX, Tang BS.
Brain Res. 2011 Apr 18;1385:293-7. Epub 2011 Feb 19.
The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease.
Zhang QJ, Li LB, Niu XL, Liu J, Gui ZH, Feng JJ, Ali U, Hui YP, Wu ZH.
Brain Res. 2011 Apr 12;1384:69-79. Epub 2011 Feb 1.
White matter connectivity of human hypothalamus.
Lemaire JJ, Frew AJ, McArthur D, Gorgulho AA, Alger JR, Salomon N, Chen C, Behnke EJ, De Salles AA.
Brain Res. 2011 Jan 31;1371:43-64. Epub 2010 Nov 29.
Brain penetrating IgG-erythropoietin fusion protein is neuroprotective following intravenous treatment in Parkinson's disease in the mouse.
Zhou QH, Hui EK, Lu JZ, Boado RJ, Pardridge WM.
Brain Res. 2011 Mar 25;1382:315-20. Epub 2011 Jan 26.
Interleukin-18 promoter polymorphisms and risk of Parkinson's disease in a Han Chinese population.
Xu X, Li D, He Q, Gao J, Chen B, Xie A.
Brain Res. 2011 Mar 24;1381:90-4. Epub 2011 Jan 15.
Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease.
Stahl K, Mylonakou MN, Skare Ø, Amiry-Moghaddam M, Torp R.
Brain Res. 2011 Mar 10;1378:105-18. Epub 2011 Jan 12.
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
McMillan PJ, White SS, Franklin A, Greenup JL, Leverenz JB, Raskind MA, Szot P.
Brain Res. 2011 Feb 10;1373:240-52. Epub 2010 Dec 11.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on